![Pablo Cabello Albendea](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pablo Cabello Albendea
President chez
Biocross SL
Profil
Pablo Cabello Albendea is the founder of Advanced Marker Discovery SL, founded in 2010, holding the title of Director.
Mr. Cabello Albendea is the founder of Cross Road Biotech Inversiones Biotecnologicas SGEIC SA, holding the title of Founding Partner.
Current jobs include President at Biocross SL, President at Raman Health Technologies SL, and Founding Partner at Cross Road Biotech Inversiones Biotecnologicas SGEIC SA. Former jobs include Chairman at Venter Pharma SL, Chairman & President at Traslational Cancer Drugs Pharma SL, Chairman & Managing Director at Inversiones Jalabun, SICAV, Biologist at Consejo Superior de Investigaciones Científicas, President at Dendrico SL from 2006 to 2012, and Biologist at Fundación Jiménez Díaz Clínica Nuestra Señora de la Concepción.
Education includes an undergraduate degree from Universidad Autónoma de Madrid.
Postes actifs de Pablo Cabello Albendea
| Sociétés | Poste | Début |
|---|---|---|
Biocross SL
 Biocross SL Medical SpecialtiesHealth Technology Designs and develops diagnostic products for neurodegenerative diseases | President | - |
Raman Health Technologies SL
 Raman Health Technologies SL BiotechnologyHealth Technology Researches and develops laser and spectroscopy-based diagnostic technology | President | - |
Cross Road Biotech Inversiones Biotecnologicas SGEIC SA
 Cross Road Biotech Inversiones Biotecnologicas SGEIC SA Investment ManagersFinance Cross Road Biotech Inversiones Biotecnologicas (CRB Inverbio) invests in companies located in Europe, mainly in Spain. The firm targets companies operating in the fields of healthcare, life sciences and biotechnology. It provides financing for early stage capital requirements with investment size ranging between EUR 2 million and EUR 4 million. It acquires both minority and majority interests. | Private Equity Investor | - |
Anciens postes connus de Pablo Cabello Albendea
| Sociétés | Poste | Fin |
|---|---|---|
Traslational Cancer Drugs Pharma SL
 Traslational Cancer Drugs Pharma SL BiotechnologyHealth Technology Discovers and develops therapeutic solutions for the treatment of cancer | Président | - |
Advanced Marker Discovery SL
 Advanced Marker Discovery SL Medical SpecialtiesHealth Technology Develops diagnostic solutions in the field of oncology | Fondateur | - |
Venter Pharma SL
 Venter Pharma SL Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Président | - |
Inversiones Jalabun, SICAV
 Inversiones Jalabun, SICAV Investment Trusts/Mutual FundsMiscellaneous Acts as Open-End Investment Fund/Unit Trust | Directeur Général | - |
Fundación Jiménez Díaz Clínica Nuestra Señora de la Concepción | Corporate Officer/Principal | - |
Formation de Pablo Cabello Albendea
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
13
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Inversiones Jalabun, SICAV
Inversiones Jalabun, SICAV Investment Trusts/Mutual FundsMiscellaneous Acts as Open-End Investment Fund/Unit Trust | Miscellaneous |
Consejo Superior de Investigaciones Científicas
 Consejo Superior de Investigaciones Científicas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Venter Pharma SL
Venter Pharma SL Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Cross Road Biotech Inversiones Biotecnologicas SGEIC SA
Cross Road Biotech Inversiones Biotecnologicas SGEIC SA Investment ManagersFinance Cross Road Biotech Inversiones Biotecnologicas (CRB Inverbio) invests in companies located in Europe, mainly in Spain. The firm targets companies operating in the fields of healthcare, life sciences and biotechnology. It provides financing for early stage capital requirements with investment size ranging between EUR 2 million and EUR 4 million. It acquires both minority and majority interests. | Finance |
Universidad Autónoma de Madrid
 Universidad Autónoma de Madrid Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Traslational Cancer Drugs Pharma SL
Traslational Cancer Drugs Pharma SL BiotechnologyHealth Technology Discovers and develops therapeutic solutions for the treatment of cancer | Health Technology |
Biocross SL
Biocross SL Medical SpecialtiesHealth Technology Designs and develops diagnostic products for neurodegenerative diseases | Health Technology |
Dendrico SL
 Dendrico SL Miscellaneous Commercial ServicesCommercial Services Develops nanotechnology systems for diagnostics and therapeutics | Commercial Services |
Fundación Jiménez Díaz Clínica Nuestra Señora de la Concepción | |
Advanced Marker Discovery SL
Advanced Marker Discovery SL Medical SpecialtiesHealth Technology Develops diagnostic solutions in the field of oncology | Health Technology |
Raman Health Technologies SL
Raman Health Technologies SL BiotechnologyHealth Technology Researches and develops laser and spectroscopy-based diagnostic technology | Health Technology |
